Kinetics of Drug‐Induced Changes in Dopamine and Serotonin Metabolite Concentrations in the CSF of the Rat
- 1 March 1984
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 42 (3) , 819-825
- https://doi.org/10.1111/j.1471-4159.1984.tb02754.x
Abstract
Cerebrospinal fluid (CSF) was removed at a constant flow rate of 1 μl/min from the third ventricle of anesthetized rats. Every 15 min, CSF dihydroxyphenyl‐acetic acid (DOPAC), homovanillic acid (HVA), and 5‐hydroxyindoleacetic acid (5‐HIAA) concentrations were determined by direct injection of CSF into a liquid chromatographic system coupled with electrochemical detection. Mean CSF concentrations of DOPAC, HVA, and 5‐HIAA were 1.29 μM, 0.88 μM, and 2.00 μM, respectively. In order to determine the turnover rates of dopamine (DA) and serotonin, experiments using monoamine oxidase (MAO) inhibition were performed. Tranylcypromine (20 mg/kg i.p.) induced a sharp exponential decrease of CSF DOPAC, HVA, and 5‐HIAA, with respective half‐lives of 15.60 min, 16.91 min, and 77.23 min. Their respective turnover rates were 3.74, 2.22, and 1.18 nmol ml−1. h−1. m‐Hydroxybenzylhydrazine (NSD‐1015, 100 mg/kg i.p.) and monofluoromethyl‐DOPA (100 mg/kg i.p.), two decarboxylase inhibitors, induced a slow exponential decrease of all three CSF metabolites, α‐Methyl‐p‐tyrosine (250 mg/kg i.p.) also induced a slow exponential decrease of DOPAC and HVA. These decreases of CSF DOPAC and HVA induced by DA synthesis inhibitors may reflect the turnover of DA in vivo. Haloperidol (0.5 mg/kg i.p.) considerably enhanced CSF DOPAC and HVA without affecting 5‐HIAA, confirming that dopaminergic receptors modulate DA neurotrans‐mission in vivo. Haloperidol administered 1.5 h after NSD‐1015 did not increase DOPAC and HVA, in contrast to reserpine (5 mg/kg i.p.) injected under the same conditions. These findings indicate that the effect of haloperidol on DA metabolites may involve newly synthesized DA, but not the DA storage pool.Keywords
This publication has 22 references indexed in Scilit:
- Probenecid sensitive pathway of elimination of dopamine and serotonin metabolites in CSF of the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Value of monoamine metabolite determinations in CSF as an index of their concentrations in rat brain following various pharmacological manipulationsJournal of Pharmacological Methods, 1982
- Rapid liquid chromatographic determination of 5-hydroxyindoles and dihydroxyphenylacetic acid in cerebrospinal fluid of the ratEuropean Journal of Pharmacology, 1982
- Simultaneous Determination of 3,4‐Dihydroxyphenylalanine, 5‐Hydroxytryptophan, Dopamine, 4‐Hydroxy‐3‐Methoxyphenylalanine, Norepinephrine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5‐Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High‐Performance Liquid Chromatography with Electrochemical DetectionJournal of Neurochemistry, 1982
- Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca Mulatta)Life Sciences, 1978
- The reserpine receptorLife Sciences, 1978
- Regulation of intracranial pressure in rat, dog, and manAnnals of Neurology, 1978
- Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areasJournal of Pharmacy and Pharmacology, 1975
- Origins of catecholamine metabolites in monkey cerebrospinal fluidJournal of Neurochemistry, 1975
- Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersNeuropharmacology, 1970